The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
892
March 19, 1993
View Complete Issue         Table of Contents 2019 
Flosequinan for Heart Failure
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Flosequinan for Heart Failure
March 19, 1993 (Issue: 892)
Flosequinan (Manoplax - Boots), a fluoroquinolone derivative, is now available in the USA for treatment of congestive heart failure. Labeling approved by the US Food and Drug Administration recommends the drug only for patients who cannot tolerate...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Flosequinan for Heart Failure
Article code: 892a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.